Efficacy of the influenza vaccine in patients with malignant lymphoma.

Clinical medicine & research

Volumn 3, Issue 4, 2005, Pages 214-220

  Mazza, Joseph J ^a   Yale, Steven H ^a   Arrowood, Jodi R ^a   Reynolds, Cory E ^a   Glurich, Ingrid ^a   Chyou, Po Huang ^a   Linneman, James G ^a   Reed, Kurt D ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; FEMALE; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LYMPHOMA; MALE; MIDDLE AGED; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LYMPHOMA; MALE; MIDDLE AGED;

EID: 39049191111     PISSN: 15394182     EISSN: None     Source Type: Journal    
DOI: 10.3121/cmr.3.4.214     Document Type: Article

References (0)